MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neureceptor status in breast cancer

Table 1 Clinical and pathological data for breast tumours analysed by microarray

Number	ID	Age (years)	Tsize (mm)	Lymph node status	Grade	UICC stage	ER	PR	HER2/neu	Subtype
1	52	49	23	Negative	1	2A	P	P	N	Luminal A
2	53	52	30	Negative	3	2A	N	N	P	Her2 overexpressing
3	54	57	45	Negative	3	2A	N	N	P	Her2 overexpressing
4	56	51	21	Negative	3	2A	P	P	N	Luminal A
5	58	68	15	Negative	3	1	P	N	N	Luminal A
6	59	42	22	Negative	3	2A	N	N	N	Triple negative
7	60	54	26	Negative	3	2A	N	P	N	Luminal A
8	61	35	22	Negative	3	2A	P	P	N	Luminal A
9	62	50	16	Negative	3	1	N	N	N	Triple negative
10	63	49	25	Negative	2	2A	N	N	N	Triple negative
11	64	59	20	Negative	3	1	N	P	N	Luminal A
12	65	58	22	Negative	3	2A	P	P	N	Luminal A
13	66	58	18	Negative	1	1	N	P	P	Her2 overexpressing
14	67	66	22	Negative	3	2A	P	P	N	Luminal A
15	94	56	17	Negative	1	1	N	N	N	Triple negative
16	95	48	30	Negative	3	2A	N	N	P	Her2 overexpressing
17	96	60	26	Negative	3	2A	P	P	N	Luminal A
18	97	56	29	Negative	2	2A	P	P	N	Luminal A
19	98	50	3	Negative	2	1	P	P	N	Luminal A
20	99	40	7	Negative	1	1	P	P	N	Luminal A
21	100	40	6	Negative	2	1	P	P	N	Luminal A
22	101	58	35	Negative	2	2A	P	P	N	Luminal A
23	102	64	34	Negative	3	2A	P	P	N	Luminal A
24	103	66	26	Negative	1	2A	P	P	N	Luminal A
25	104	84	16	Negative	2	1	N	P	N	Luminal A
26	105	57	7	Negative	3	1	N	P	N	Luminal A
27	106	68	35	Negative	3	2A	P	P	N	Luminal A
28	107	40	20	Negative	2	1	P	P	P	Luminal B
29	108	49	35	Negative	3	2A	N	N	N	Triple negative

ER, oestrogen receptor; HER2/neu, v-erb-b2 erythroblastic leukaemia viral oncogene homolog 2 receptors; ID, identification; N, negative confirmed; PR, progesterone receptor; P, positive confirmed; Tsize, Tumour size in mm; UICC, stage of breast tumour according to the international union against cancer staging criteria.

ISSN: 1465-542X